We are live on ! Find out more
BCTXL

BriaCell Therapeutics Warrant
BCTXL

15 hedge funds and large institutions have $3.7M invested in BriaCell Therapeutics Warrant in 2026 Q1 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

127.95% more ownership

Funds ownership: 0% → 127.95% (+128%)

Holders
15
Holders Change
+15
Holders Change %
–
% of All Funds
0.18%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
15
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$1.11M
2
AC
Armistice Capital
New York
+$568K
3
SM
Sabby Management
Florida
+$403K
4
CCC
Cable Car Capital
California
+$341K
5
EAM
Empery Asset Management
New York
+$318K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$1.05M +$1.11M +1,048,759 New
AC
2
Armistice Capital
New York
$553K +$568K +536,600 New
SM
3
Sabby Management
Florida
$392K +$403K +380,686 New
CCC
4
Cable Car Capital
California
$332K +$341K +321,898 New
EAM
5
Empery Asset Management
New York
$309K +$318K +300,000 New
HCM
6
Heights Capital Management
California
$300K +$318K +300,000 New
MA
7
MYDA Advisors
New York
$206K +$212K +200,000 New
Hudson Bay Capital Management
8
Hudson Bay Capital Management
Connecticut
$125K +$133K +125,402 New
WAM
9
Warberg Asset Management
Illinois
$118K +$122K +115,000 New
CS
10
Clear Street
New York
$107K +$110K +104,196 New
BFM
11
Boothbay Fund Management
New York
$83.8K +$21.2K +20,000 New
IAM
12
Iridian Asset Management
Connecticut
$67K +$68.8K +65,000 New
LCM
13
LuminArx Capital Management
New York
$25.8K +$26.5K +25,000 New
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
$23.9K +$25.3K +23,889 New
FIA
15
FNY Investment Advisers
New York
$7K +$7.94K +7,500 New

BCTXL Hedge Fund Activity: Q1 2026 in Review

15 of the 8,132 institutional investors tracked by Wall St. Rank reported a position in BriaCell Therapeutics Warrant (BCTXL) for Q1 2026, worth a combined $3.7M.

Buyers outnumbered sellers: 15 funds opened new BCTXL positions and 0 closed out — a net gain of 15 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $1.11M.

  • 15 institutional investors held BriaCell Therapeutics Warrant (BCTXL) as of Q1 2026, up from 0 in Q4 2025.
  • Funds reported $3.7M of BriaCell Therapeutics Warrant stock for Q1 2026.
  • 15 funds opened new BriaCell Therapeutics Warrant positions in Q1 2026 and 0 closed out, a net change of +15 holders.
  • The largest BriaCell Therapeutics Warrant buyer in Q1 2026 was Citadel Advisors, an estimated $1.11M added.

Based on aggregated 13F filings for Q1 2026.